(Q43995966)

English

Administration of ghrelin improves inflammation, oxidative stress, and apoptosis during and after non-alcoholic fatty liver disease development

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

28 November 2017

Administration of ghrelin improves inflammation, oxidative stress, and apoptosis during and after non-alcoholic fatty liver disease development (English)

1 reference

Europe PubMed Central

28 November 2017

0 references

metabolic dysfunction–associated steatotic liver disease

1 reference

based on heuristic

inferred from title

non-alcoholic fatty liver

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Yan Li

1

1 reference

Europe PubMed Central

28 November 2017

Jie Hai

2

1 reference

Europe PubMed Central

28 November 2017

Lake Li

3

1 reference

Europe PubMed Central

28 November 2017

Xuehui Chen

4

1 reference

Europe PubMed Central

28 November 2017

Hua Peng

5

1 reference

Europe PubMed Central

28 November 2017

Meng Cao

6

1 reference

Europe PubMed Central

28 November 2017

Qinggui Zhang

7

1 reference

Europe PubMed Central

28 November 2017

publication date

29 July 2012

1 reference

Europe PubMed Central

28 November 2017

1 reference

Europe PubMed Central

28 November 2017

43

1 reference

Europe PubMed Central

28 November 2017

2

1 reference

Europe PubMed Central

28 November 2017

376-386

1 reference

Europe PubMed Central

28 November 2017

https://scigraph.springernature.com/pub.10.1007/s12020-012-9761-5

0 references

Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9761-5

21 January 2018

The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9761-5

21 January 2018

Inflammation in nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9761-5

21 January 2018

Apoptosis in nonalcoholic fatty liver disease: diagnostic and therapeutic implications

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9761-5

21 January 2018

The role of oxidative stress in non-alcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9761-5

21 January 2018

Ghrelin, appetite, and gastric motility: the emerging role of the stomach as an endocrine organ

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9761-5

21 January 2018

Ghrelin is a growth-hormone-releasing acylated peptide from stomach

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9761-5

21 January 2018

Ghrelin in the regulation of body weight and metabolism

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9761-5

21 January 2018

Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9761-5

21 January 2018

Low Plasma Ghrelin Is Associated With Insulin Resistance, Hypertension, and the Prevalence of Type 2 Diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9761-5

21 January 2018

Ghrelin suppresses glucose-stimulated insulin secretion and deteriorates glucose tolerance in healthy humans

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9761-5

21 January 2018

Ghrelin ameliorates TNF-a induced anti-proliferative and pro-apoptotic effects and promotes intestinal epithelial restitution

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9761-5

21 January 2018

Exogenous ghrelin modulates release of pro-inflammatory and anti-inflammatory cytokines in LPS-stimulated macrophages through distinct signaling pathways

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9761-5

21 January 2018

Therapeutic action of ghrelin in a mouse model of colitis.

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9761-5

21 January 2018

Orexigenic hormone ghrelin attenuates local and remote organ injury after intestinal ischemia-reperfusion

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9761-5

21 January 2018

Ghrelin alleviates biliary obstruction-induced chronic hepatic injury in rats

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9761-5

21 January 2018

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9761-5

21 January 2018

Increased expression of cytochrome P450 2E1 in nonalcoholic fatty liver disease: mechanisms and pathophysiological role

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9761-5

21 January 2018

Caspases: opening the boxes and interpreting the arrows

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9761-5

21 January 2018

Apoptosis and cancer: mutations within caspase genes

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9761-5

21 January 2018

Impaired PI3K/Akt signal pathway and hepatocellular injury in high-fat fed rats

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9761-5

21 January 2018

Rutin attenuates metabolic changes, nonalcoholic steatohepatitis, and cardiovascular remodeling in high-carbohydrate, high-fat diet-fed rats.

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9761-5

21 January 2018

Involvement of AMP-activated protein kinase in beneficial effects of betaine on high-sucrose diet-induced hepatic steatosis

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9761-5

21 January 2018

Green tea extract attenuates hepatic steatosis by decreasing adipose lipogenesis and enhancing hepatic antioxidant defenses in ob/ob mice

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9761-5

21 January 2018

The current state of serum biomarkers of hepatotoxicity.

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9761-5

21 January 2018

In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9761-5

21 January 2018

Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9761-5

21 January 2018

Ghrelin attenuates hepatocellular injury and liver fibrogenesis in rodents and influences fibrosis progression in humans

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9761-5

21 January 2018

Investigating the mechanism for AMP activation of the AMP-activated protein kinase cascade

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9761-5

21 January 2018

Nordihydroguaiaretic acid protects against high-fat diet-induced fatty liver by activating AMP-activated protein kinase in obese mice

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9761-5

21 January 2018

Ghrelin inhibits post-infarct myocardial remodeling and improves cardiac function through anti-inflammation effect.

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9761-5

21 January 2018

The natural history of nonalcoholic fatty liver: a follow-up study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22843123

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

From fat to inflammation

1 reference

https://pubmed.ncbi.nlm.nih.gov/22843123

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased hepatocyte CYP2E1 expression in a rat nutritional model of hepatic steatosis with inflammation

1 reference

https://pubmed.ncbi.nlm.nih.gov/22843123

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ghrelin ameliorates pancreaticobiliary inflammation and associated remote organ injury in rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/22843123

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ghrelin protects against experimental sepsis by inhibiting high-mobility group box 1 release and by killing bacteria

1 reference

https://pubmed.ncbi.nlm.nih.gov/22843123

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nonalcoholic steatohepatitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22843123

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22843123

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

AMP-activated protein kinase, a metabolic master switch: possible roles in type 2 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/22843123

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Melatonin ameliorates nonalcoholic fatty liver induced by high-fat diet in rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/22843123

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatoprotective effect of ghrelin on carbon tetrachloride-induced acute liver injury in rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/22843123

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12020-012-9761-5

1 reference

Europe PubMed Central

28 November 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

28 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43995966&oldid=2105519440"